Antares Pharma

$3.42 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Antares Pharma

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

Stock Analysis

last close $3.43
1-mo return 3.9%
3-mo return -3.1%
avg daily vol. 539.23T
52-week high 5.07
52-week low 3.11
market cap. $607M
forward pe 30.6
annual div. -
roe 63.1%
ltg forecast -
dividend yield -
annual rev. $179M
inst own. 50.3%
baraka

Subscribe now for daily local and international financial news

Subscribe